Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals
- PMID: 1570298
- PMCID: PMC525577
- DOI: 10.1073/pnas.89.9.3795
Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals
Abstract
Spontaneous inhibitors of factor VIII (FVIII) are pathogenic IgG autoantibodies of restricted isotypic heterogeneity found in the plasma of patients presenting with bleeding episodes and low levels of FVIII. We now report the presence of a natural FVIII-neutralizing activity in 85 of 500 plasma samples (17%) from healthy donors. FVIII-inhibitory activity was present in F(ab')2 fragments of purified IgG and was dose-dependent. The titer of anti-FVIII antibodies in normal plasma ranged between 0.4 (threshold of detection) and 2.0 Bethesda units. Anti-FVIII IgG was also detected in normal plasma by using an ELISA. Anti-FVIII antibodies from healthy individuals did not exhibit restricted isotypic heterogeneity. Mean levels of FVIII activity did not differ significantly between individuals with and without detectable anti-FVIII antibodies in plasma. Natural anti-FVIII IgG inhibited FVIII activity in pools of normal plasma and in plasma of certain donors in the pool but did not inhibit FVIII activity in autologous plasma. These observations demonstrate that polyclonal IgG antibodies against procoagulant FVIII are present in healthy individuals. The antibodies are natural IgG autoantibodies and/or antibodies directed against epitopes associated with a so far unidentified allotypic polymorphism of the human FVIII molecule.
Similar articles
-
Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.Proc Natl Acad Sci U S A. 1987 Feb;84(3):828-31. doi: 10.1073/pnas.84.3.828. Proc Natl Acad Sci U S A. 1987. PMID: 3101065 Free PMC article.
-
Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.Acta Haematol. 2005;114(2):84-90. doi: 10.1159/000086580. Acta Haematol. 2005. PMID: 16103630
-
Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.Ann Hematol. 1996 May;72(5):321-6. doi: 10.1007/s002770050179. Ann Hematol. 1996. PMID: 8645745
-
Autoantibodies to factor VIII.Autoimmun Rev. 2002 Feb;1(1-2):105-10. doi: 10.1016/s1568-9972(01)00017-9. Autoimmun Rev. 2002. PMID: 12849066 Review.
-
B-cell and T-cell epitopes in anti-factor VIII immune responses.Clin Rev Allergy Immunol. 2009 Oct;37(2):80-95. doi: 10.1007/s12016-009-8120-7. Clin Rev Allergy Immunol. 2009. PMID: 19184559 Review.
Cited by
-
Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A.Hemasphere. 2021 Apr 21;5(5):e557. doi: 10.1097/HS9.0000000000000557. eCollection 2021 May. Hemasphere. 2021. PMID: 33898928 Free PMC article.
-
Tolerating Factor VIII: Recent Progress.Front Immunol. 2020 Jan 10;10:2991. doi: 10.3389/fimmu.2019.02991. eCollection 2019. Front Immunol. 2020. PMID: 31998296 Free PMC article. Review.
-
Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death.J Matern Fetal Neonatal Med. 2009 Aug;22(8):662-71. doi: 10.1080/14767050902801751. J Matern Fetal Neonatal Med. 2009. PMID: 19591071 Free PMC article.
-
Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults.Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3839-43. doi: 10.1073/pnas.92.9.3839. Proc Natl Acad Sci U S A. 1995. PMID: 7731992 Free PMC article.
-
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic review.EJHaem. 2023 Mar 10;4(2):532-543. doi: 10.1002/jha2.604. eCollection 2023 May. EJHaem. 2023. PMID: 37206259 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources